SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors grow increasingly skeptical of its high AI capital expenditures and the competitive threat to its core software business. The community is sharply divided, with many retail traders venting frustration over the stock's persistent, decoupling decline while others characterize the current valuation as a generational buying opportunity.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant investor interest as a high-concentration proxy for SpaceX, with market participants closely monitoring reports of an imminent IPO filing. The community is actively debating the fund's valuation relative to its NAV compared to other venture-focused investment vehicles, while anticipating that institutional demand for private unicorn exposure will drive further volatility.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently trading with extreme volatility as the community remains sharply divided between those calling for a broader structural breakdown and bulls pointing to the company's AI-driven advertising platform and upcoming fireside chat as key growth catalysts. The stock continues to be a battleground for retail traders, with ongoing debates centered on whether recent price swings are driven by coordinated short campaigns, insider selling, or institutional positioning ahead of sector rotation.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as investors react to positive Phase 3 results for Zenkuda in diabetic retinopathy, which met its primary endpoint and showed significant superiority over sham treatment. The community is actively debating the stock's potential for a broader repricing and recovery, closely monitoring institutional positioning from major stakeholders like Baker Bros against the backdrop of historical volatility and high short interest.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to optimistic investor sentiment and analyst upgrades surrounding its obesity candidate, WVE-007, which has shown competitive fat loss results and muscle preservation in early clinical data. The community is actively discussing the stock's potential as a lucrative M&A target for major pharmaceutical firms, balancing excitement over its RNA platform against concerns regarding volatility, insider selling, and potential dilution from financing activities.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy ($RAGE) is trending as the community doubles down on the revival of the iconic early 2000s meme culture, actively promoting its presence on the Solana network through community-driven building and comic creation. Enthusiasts are rallying behind the project as an 'OG' meme, emphasizing sustained daily engagement and the restoration of legacy web domains to solidify its place in internet history.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is currently trending as investors weigh strong AI data center demand against frustration over management's communication and the stock's recent volatility. While the community remains divided, many are focused on the company's potential to capitalize on the AI compute bottleneck, with active discussions centering on the long-term value of their infrastructure versus short-term price pressure and execution concerns.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is seeing significant investor attention following the FDA approval of Optune Pax for locally advanced pancreatic cancer, the first new treatment for the condition in nearly three decades. While the community is actively debating the company's long-term commercial execution and the impact of recent Medicare billing challenges, sentiment remains divided between those betting on a potential short squeeze and those skeptical of management's ability to drive sustained revenue growth.

The Shrimp Army

SHRIMPS is gaining traction as part of a broader, community-led wave of ocean-themed meme coins on the Solana network, with traders actively debating its potential to erase zeros and mirror the rapid momentum of similar viral tokens. While some participants are hyping the asset for significant upside, others remain cautious, warning of high volatility and the risks of a rapid dump typical of speculative low-cap crypto projects.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors aggressively position themselves ahead of upcoming earnings, with significant market discussion focused on its role as a critical AI infrastructure and 6G powerhouse rather than its legacy hardware business. Community sentiment is largely bullish, driven by institutional accumulation, strategic partnerships with companies like Nvidia, and ongoing developments in optical networking and defense-related projects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ocular Therapeutix Touts Landmark Phase 3 AXPAXLI Win at RBC Ophthalmology Conference

Ocular Therapeutix (NASDAQ:OCUL) executives highlighted what the company described as a landmark Phase 3 outcome for its retinal disease candidate AXPAXLI and discussed ongoing development, safety...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Rating of "Moderate Buy" from Analysts

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) has been assigned an average rating of "Moderate Buy" from the fourteen research firms that are presently covering the stock, MarketBeat...

Cantor Fitzgerald L. P. Buys Shares of 201,865 Ocular Therapeutix, Inc. $OCUL

Cantor Fitzgerald L. P. purchased a new stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) during the third quarter, according to its most recent filing with the SEC. The firm purchased 201,865 shares of the biopharmaceutical company's stock, valued at approximately $2,360,000. Cantor Fi...

What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down

Key PointsAdviser, LLC Sold 5,845,915 shares of Ocular Therapeutix; estimated transaction value $71.01 million based on quarterly average price...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Short Interest Up 20.0% in February

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling...

Ocular Therapeutix, Inc. $OCUL Shares Purchased by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC grew its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 38.5% in the 3rd quarter, according to its most recent disclosure with the Securities and...

Rosalind Advisors Inc. Decreases Stock Position in Ocular Therapeutix, Inc. $OCUL

Rosalind Advisors Inc. decreased its stake in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 67.2% during the 3rd quarter, according to the company in its most recent filing with...

Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?

Relay Therapeutics (RLAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Ocular Therapeutix, Inc. $OCUL Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 9.2% during the third quarter, according to the company in its most recent 13F filing with the...

Short Interest in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Grows By 27.8%

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) saw a significant increase in short interest in February. As of February 13th, there was short interest totaling 14,706,215 shares, an...

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

OCUL
Ocular Therapeutix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OCUL News

OCULOcular Therapeutix Inc